Metagenomi, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGX and other ETFs, options, and stocks.About MGX
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform.
CEOJian Irish
CEOJian Irish
Employees202
Employees202
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2016
Founded2016
Employees202
Employees202
MGX Key Statistics
Market cap66.83M
Market cap66.83M
Price-Earnings ratio-0.75
Price-Earnings ratio-0.75
Dividend yield—
Dividend yield—
Average volume389.35K
Average volume389.35K
High today$1.82
High today$1.82
Low today$1.73
Low today$1.73
Open price$1.78
Open price$1.78
Volume406.89K
Volume406.89K
52 Week high$4.92
52 Week high$4.92
52 Week low$1.23
52 Week low$1.23
Stock Snapshot
Metagenomi, Inc.(MGX) stock is priced at $1.78, giving the company a market capitalization of 66.83M. It carries a P/E multiple of -0.75.
During the trading session on 2025-12-07, Metagenomi, Inc.(MGX) shares reached a daily high of $1.82 and a low of $1.73. At a current price of $1.78, the stock is +2.9% higher than the low and still -2.2% under the high.
Trading volume for Metagenomi, Inc.(MGX) stock has reached 406.89K, versus its average volume of 389.35K.
The stock's 52-week range extends from a low of $1.23 to a high of $4.92.
The stock's 52-week range extends from a low of $1.23 to a high of $4.92.
People also own
Based on the portfolios of people who own MGX. This list is generated using Robinhood data, and it’s not a recommendation.